Efficacy and feasibility of sorafenib as a maintenance agent after allogeneic hematopoietic stem cell transplantation for Fms‐like tyrosine kinase 3‐mutated acute myeloid leukemia

Giorgia Battipaglia, Annalisa Ruggeri, Radwan Massoud, +19

Cancer

Comparison of immune reconstitution between anti-T-lymphocyte globulin and posttransplant cyclophosphamide as acute graft-versus-host disease prophylaxis in allogeneic myeloablative peripheral blood stem cell transplantation

Radwan Massoud, Nico Gagelmann, Ulrike Fritzsche‐Friedland, +6

Haematologica

Cell TherapyGvhd ProphylaxisImmunologyPathologyNatural Killer T +18

Mutant H3 histones drive human pre-leukemic hematopoietic stem cell expansion and promote leukemic aggressiveness

Meaghan Boileau, Margret Shirinian, Tenzin Gayden, +23

Nature Communications

Nivolumab salvage therapy before or after allogeneic stem cell transplantation in Hodgkin lymphoma

Jean El Cheikh, Radwan Massoud, Basel Haffar, +6

Bone Marrow Transplantation

Lymphoid NeoplasiaCell TherapyHodgkin LymphomaTransplantationMarrow Transplantation +9

Low-dose 5-azacytidine as preventive therapy for relapse of AML and MDS following allogeneic HCT

Jean El Cheikh, Radwan Massoud, Elie-Jacques Fares, +5

Bone Marrow Transplantation

Preventive TherapyOncologyPharmacologyPharmacotherapyMedicine +1

Efficacy and Feasibility of Sorafenib as a Maintenance Agent After Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Mutated Acute Myeloid Leukemia: An Update

Giorgia Battipaglia, Radwan Massoud, Syed Osman Ahmed, +6

Clinical Lymphoma Myeloma & Leukemia

Hematological MalignancyMaintenance AgentCell TherapyTransplantationMarrow Transplantation +9

Impact of Adding Antithymocyte Globulin to Posttransplantation Cyclophosphamide in Haploidentical Stem-Cell Transplantation

Jean El Cheikh, Raynier Devillier, Rémy Duléry, +13

Clinical Lymphoma Myeloma & Leukemia

Adding Antithymocyte GlobulinCell TherapyTransplantationMarrow TransplantationStem Cell Transplantation +7

Hyper-CVAD Compared With BFM-like Chemotherapy for the Treatment of Adult Acute Lymphoblastic Leukemia. A Retrospective Single-Center Analysis

Jean El Cheikh, Imane El Dika, Radwan Massoud, +4

Clinical Lymphoma Myeloma & Leukemia

Hematological MalignancyMedicineHematologyClinical TrialsPharmacotherapy +8

Feasibility of the Combination of Venetoclax and Asparaginase-based Chemotherapy for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia

Jean El Cheikh, Nour Moukalled, Haidar El Darsa, +4

Clinical Lymphoma Myeloma & Leukemia

Hematological MalignancyLymphoid NeoplasiaOncologyAdult PatientsPathology +3

Enhanced Immune Reconstitution of γδ T Cells after Allogeneic Stem Cell Transplantation Overcomes the Negative Impact of Pretransplantation Minimal Residual Disease-Positive Status in Patients with Acute Myelogenous Leukemia

Evgeny Klyuchnikov, Anita Badbaran, Radwan Massoud, +6

Transplantation and Cellular Therapy